Antimicrobial Susceptibility Testing Market by Product (Manual Automated Susceptibility Testing Product, Automated Laboratory Instruments), Type (Antibacterial, Antifungal, Antiparacitic), Application (Clinical Diagnostics, Drug Discovery), End-User (Hospitals, Pharmaceutical companies, Clinical Research) – Global Analysis & Forecast, 2020 – 2027

    14-January-2021 | 209 Pages | | Report Code : RC-260

The Global Antimicrobial Susceptibility Testing Market is expected to grow steadily at a CAGR of 5.4% from 2020 to 2027.The increase in a number of epidemic outbreaks caused by infectious pathogens such as Neisseria meningitides, Neisseria gonorrhoeae, Salmonella serotype Typhi, Streptococcus pneumoniae, and Vibrio cholera, is fueling the demand for antimicrobial susceptibility testing products.

North America is the prominent market for antimicrobial susceptibility testing driven by technological advancement and rising incidence of infectious diseases. The increasing R&D to develop novel automated AST systems, and safety concerns are also supporting market growth in the region.The Asia-Pacific region is projected to attain the fastest CAGR in the coming years. The factors such as increased demand for advanced disease diagnostic techniques, increase in healthcare expenditure, and improving healthcare infrastructure are boosting the market growth in the countries such as China and India.

Growing awareness of precision medicine and the increasing prevalence of multidrug-resistant organisms are major drivers boosting the market growth. As per the data generated by the Centers for Disease Control and Prevention, in the U.S., more than 2.8 million antibiotic-resistant infections happen every year, out of which 35,000 people die. Therefore, the need for antimicrobial susceptibility testing is at an increasing pace owing to the growth in a number of multidrug-resistant diseases. However, stringent regulatory government policies are limiting market growth and expected to affect throughout the forecast period.

The global antimicrobial susceptibility testing market is segmented by type, product,application, and end-user. By product,the market is segmented into manual antimicrobial susceptibility testing products, automated laboratory instruments, culture and growth media, and consumables. The type segment is divided into antibacterial, antifungal, and antiparasitic. By application, the market is segregated into drug discovery and development, clinical diagnostics, and epidemiology. By end-user, the market is segmented as pharmaceutical and biotechnology companies, hospitals and diagnostic centers, research &academic institutes, and clinical research organizations.

North America, Europe, Asia-Pacific, andLAMEA are the geographical breakdowns of the antimicrobial susceptibility testing market at the global level. Moreover, the country-wise market analysis has been also covered under the scope of the report.

The leading key players in the antimicrobial susceptibility testing market are Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bruker, Roche Diagnostics Limited, Accelerate Diagnostics, Inc., Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, Hi-Media Laboratories, Creative Diagnostics, Synbiosis, ZHUHAI DL BIOTECH Co., Ltd., ELITechGroup, Mast Group Ltd.,LiofilchemS.r.l., AlifaxS.r.l., CONDALAB, Genefluidics, Inc., Biotron Ltd, InvivoGen, PML Microbiologicals Inc.,MP Biomedicals, QuantaMatrix Inc., and among others.


Antimicrobial Susceptibility Testing MarketKey Segments:

Product Segments

•  Manual Antimicrobial Susceptibility Testing Products
   o  Susceptibility Testing Disks
   o  MIC Strips
   o  Susceptibility Testing Plates

  Automated Laboratory Instruments
  Culture and Growth Media


Type Segments

  Antibacterial Susceptibility Testing
  Antifungal Susceptibility Testing
  Antiparasitic Susceptibility Testing
  Other Susceptibility Testing Types


Application Segments

  Clinical Diagnostics
  Drug Discovery and Development
  Other Applications


End-User Segments

  Hospitals and Diagnostic Centers
  Pharmaceutical and Biotechnology Companies
  Research &Academic Institutes
  Clinical Research Organizations (CROs)


Geographical Segments

•  North America
   o  The U.S.
   o  Canada
   o  Mexico

•  Europe
   o  UK
   o  Germany
   o  France
   o  Italy
   o  Spain
   o  Rest of Europe

•  Asia-Pacific
   o  India
   o  China
   o  Japan
   o  Australia
   o  South Korea
   o  Rest of Asia-Pacific

   o  Latin America
   o  The Middle East
   o  Africa



Ask For Customization of Report

Request For Report Sample

Ask For Discount


Abstract Market Research

Call at: +1-209-813-4101 | +91-9730047721

Send us an Email